ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.
In the “Technology, Digital Transformation, and Pharma 4.0™” track at the upcoming 2025 ISPE Facilities of the Future Conference, audiences will have the opportunity to learn how cross-industry...
The 2024 ISPE International Honor Awards enable the ISPE community to recognize and celebrate the dedicated professionals who volunteer countless hours to support ISPE and its mission. This year’s awards were presented in October at the 2024 ISPE Annual Meeting & Expo in Orlando, Florida, USA.
As the pharmaceutical industry continues to evolve at an unprecedented rate, the design and delivery of manufacturing facilities must keep pace with the associated changing requirements. The drivers for change are also diverse both with internal and external factors being relevant. For facility design this means a more focused risk-based approach is followed. The result is facilities which...
In the fast-paced and ever-evolving world of pharmaceutical manufacturing, companies must respond to and navigate complex challenges to minimize risks and assure their manufacturing strategies deliver measurable value. As businesses evaluate whether to modify, expand or design new facilities, they must define and develop a robust and resilient framework for their manufacturing spaces and...
The 2024 ISPE International Honor Awards, presented at the 2024 ISPE Annual Meeting & Expo, enable the ISPE community to recognize and celebrate ISPE members who go above and beyond in supporting ISPE and its...
Expanding on the traditional focus of ISPE’s Facility of the Year Awards (FOYA), United Therapeutics has earned an Honorable Mention in the Social Impact category for their extraordinary...
In 2024, the Facility of the Year Awards (FOYA) honored Zydus Pharmaceuticals with an Honorable Mention for their state-of-the-art Oral Solid Dosage (OSD) manufacturing facility in Ahmedabad, Gujarat, India. This recognition highlights Zydus’s commitment to innovation, efficiency, and patient accessibility within the pharmaceutical industry.
ISPE has announced the new 2024-2025 ISPE Affiliate and Chapter Council Chairs and Co-Chairs. ISPE Regional Affiliate Councils collaborate efficiently with the international ISPE organization and local regional peers to ensure optimal alignment and support for local success. ISPE currently has three regional affiliate councils including: Asia-Pacific Affiliate Council (APAC), European...
In 2020, CSL initiated a benchmarking activity with a small group of peer companies identified through ISPE to explore creation and maturation of Asset Management programs at each company. The initial sessions were a success, covering topics such as Asset Condition Evaluations and Asset Management Governance. CSL was keen to continue the conversations and gather more insights on certain...
At the 2024 ISPE Annual Meeting & Expo, in Orlando, Florida, this past October, ISPE proudly recognized Niranjan Kulkarni, PhD, with the prestigious Max Seales Yonker Award, as part of the 2024 International Honor Awards. Kulkarni was honored for his extraordinary volunteer service, leadership, and unwavering commitment to...
Advanced therapy medicinal products (ATMPs) are medicines based on genes, tissues, or cells. This class of products cannot be terminally sterilized and, in many cases, cannot be filtered and are manufactured by Aseptic processing. The increase in demand for these life-changing products has been fraught with technical and regulatory challenges as laboratory processes are scaled to commercial...
ISPE’s Pharma 4.0™ Baseline Guide authoring team received the prestigious Committee of the Year Award, as part of the 2024 ISPE International Honor Awards which were presented at this year’s 2024 ISPE Annual Meeting & Expo., The Committee of the Year Award recognized the Pharma 4.0™ Baseline Guide Authoring Team for their...
The pharmaceutical industry is undergoing a remarkable transformation, with advanced modalities like antibody-drug conjugates (ADCs) and radiopharmaceuticals driving the evolution of precision medicine. These innovations are not only redefining drug development but are also improving patient outcomes through targeted therapies, reduced side effects, and expanded treatment options. The...
On 16 October at the 2024 ISPE Annual Meeting & Expo in Orlando, Florida, USA, Emer Cooke, European Medicines Agency (EMA) Executive Director and chair of the International Coalition of Medicines...
In this blog post, Charlie Wakeham, Director of WakeUp to Quality and Chair of the ISPE GAMP® Global Steering Committee, shares a recap of the ISPE Australasia Digital Innovation Conference, which took place 24 – 25 September 2024.
All economic sectors, including life sciences, are undergoing a significant transformation driven by the increasing focus on integrating environmental, social, and governance (ESG) criteria into their strategies and activities. This shift is crucial as companies face growing pressures from stakeholders such as customers, regulators, suppliers, and employees to act responsibly and...
Designing a monoclonal antibody (mAbs) production facility presents a series of unique challenges, balancing regulatory compliance, efficiency, sustainability and flexibility. Through careful planning and design, companies can create production environments that meet growing demands while optimizing operational efficiency.
